Around the Practice: Optimizing Patient Care for Advanced Non–Clear Cell RCC : Episode 5

nccRCC: Alternative Therapies

September 20, 2024

By Moshe Ornstein, MD, MA
Karine Tawagi, MD

Opinion

Video

Medical experts discuss clinical trials supporting alternative therapies for advanced non–clear cell RCC, including Cabo alone, Nivo + Cabo, and others, and whether these studies covered all histologies.

EP: 1.Overview of RCC: Clear-Cell and Non–clear Cell

EP: 2.Challenges in Treating RCC From Community and Academic Settings

EP: 3.Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates

EP: 4.KEYNOTE-B61: Clinical Implications of Efficacy and Safety Data in Practice

Now Viewing

EP: 5.nccRCC: Alternative Therapies

EP: 6.Role of Histology and Data in Selecting Optimal Therapy in nccRCC

EP: 7.AE Management of IO/TKI and Future of nccRCC

EP: 8.KEYNOTE-564: Pembrolizumab as Adjuvant Therapy

EP: 9.NCCN Guideline Updates in Clear-Cell RCC

EP: 10.Best Treatment Selection in Clear-Cell RCC

Video content above is prompted by the following:

Discuss the clinical trials supporting other preferred therapies in advanced nccRCC. Were these studies done across all histologies?

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!